|Table of Contents|

EFFECTS OF SOYBEAN PEPTIDES ON BLOOD LIPIDS IN HYPERLIPIDEMIA RATS(PDF)

《大豆科学》[ISSN:1000-9841/CN:23-1227/S]

Issue:
2007年05期
Page:
752-756
Research Field:
Publishing date:

Info

Title:
EFFECTS OF SOYBEAN PEPTIDES ON BLOOD LIPIDS IN HYPERLIPIDEMIA RATS
Author(s):
BAO Le-uanZHANG Ye-iQIAN LeiWANG Jian-ingZOU JingLU Fu-ingDU Lian-iang
Tianjin Key Lab of Industrial Microbiology,College of Biotechnology,Tianjin University of Science & Technology,Tianjin 300457
Keywords:
Soybean peptides Lipid Antioxidation Lipid hemorheolgy
PACS:
R962
DOI:
10.3969/j.issn.1000-9841.2007.05.024
Abstract:
To observe the effects of soybean peptides on regulation of liquid metabolism,hemorheological indexes,antioxidation in rats with hyperlipidemia.Sixty-three SD rats were randomly divided into seven groups as normal control group,model control group,Xuezhikang (100 mg kg-1d-1,i.p.) group,soybean peptide (400 mg kg-1d-1 ,i.g.) group,soybean peptide (800 mg kg-1d-1 ,i.g.) group,soybean peptide (100 mg kg-1d-1,i.p.) group and soybean peptide (400 mg kg-1d-1 ,i.p.) group.All rats were fed with high-lipid forage except normal control group.Soybean peptides were administered continually for 30 days and blood was collected to detect TC、TG and HDL.C in serum once every two weeks and the levels of serum SOD、MDA and NO were assayed at the last day.Results showed that soybean peptides could significantly decrease TC、TG and LDL-C levels in experimental hyperlipidemia rats (P<0.05),but it had no significant effect on the level of HDL.C (P>0.05)The activity of SOD in rats of soybean peptides administered groups were much higher than those of model control group (P<0.05).Meanwhile,the MDA and NO levels in rats of soybean peptides administered groups were much lower than those of model control group (P<0.05).The results suggested that the Soybean Peptides can regulate the liquid metabolism,improve hemorheological indexes,increase the activity of scavenging free radicals in rats with hyperlipidemia.

References:

[1]李佃淳,张红,李玉中,等.复方芪参降脂饮抗实验性动脉粥样硬化作用及其可能机制[J].中国临床药学杂志,2006,15(3):156-159.

[2]李宝华,郑广娟,张文高,等.软脉降脂胶囊对实验性高脂血症大鼠血脂及MDA、SOD、NO的影响[J].中西医结合心脑血管病杂志,2004,2(4):220-222.
[3]沃兴得,崔小强,唐利华.姜黄素对食耳性高脂血症大鼠血浆蛋白代谢相关酶活性的影响[J].中国动脉硬化杂志,2003,11(3):223-226.
[4]高春霞.大豆多肽生理活性、应用与前景分析[J].大豆通报,2006,19(4):18-22.
[5]江和源,吕飞杰,邰建祥.大豆中生物活性成分及其功能[J].大豆科学,2000,19(2):160-164.
[6]赵秀娟,王小雪,吴博学,等.大豆活性肽粉对喂饲高脂饲料大鼠血脂的影响[J].中国卫生检验杂志,2002,12(4):421-422.
[7]汪庆辉,崔东善,林杨,等.大豆蛋白肽加工工艺技术概述[J].大豆通报,2001,19(4):18-19.
[8]钱磊,包乐媛,鄂旭,等.脱脂豆粕酶法制备大豆肽[J].化学与生物工程,2007,24(3):39-43.
[9]赵秀娟,贾莉,赵云财.大豆活性肽对大鼠体内高胆固醇代谢的影响[J].中国公共卫生,2004,20(9):1094-1096.
[10]刘忆梅,陈朝晖.大豆蛋白肽降血脂功能性的研究[J].大豆通报,2004,19(3):22.
[11]任世存,任延明,乔晓鸣.沙棘降脂胶囊对高脂血症大鼠脂代谢及血液流变学影响的研究[J].江苏中医药,2005,26(8):52-53.
[12]朱艳媚,多杰,陈秋红.金诃降脂胶囊对高脂血症大鼠血脂和血液流变学的影响[J].青海医学院学报,2004,25(2):101-103.
[13]成龙,梁日欣,杨滨,等.红花提取物对高脂血症大鼠降脂和抗氧化的实验研究[J].中国实验方剂学杂志,2006,12(9):25-27.
[14]朱慧娟,赵岩,李世芬,等.大豆提取物抗氧化作用研究[J].江苏卫生保健,2007,9(1):5-6.

Memo

Memo:
-
Last Update: 2014-10-20